Premji Invest
Portfolio in India · United States: 2 funded startups tracked by Uback, 2 of them in a ranking.
Portfolio on Uback2startups, 2 countries
In a ranking2ranked by AI-estimated valuation
On the Radar0eligible, not ranked
Latest deal trackedSep 2025Kriya Therapeutics
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| Purplle | #38 India | Commerce › beauty e-commerce and private labels | Series F · USD ~178M (INR 1,500 cr) · Oct 2024 | Hundreds of M$ |
| Kriya Therapeutics | #3 Gene & cell therapies | Healthtech › Biotech › Gene & cell therapies | Series D · USD 320M · Sep 2025 | Unicorn |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12024
12025
Co-investors
ADIA · Patient Square Capital
Investors that joined the same rounds, as reported by public sources.
Sources. forgeglobal.com, inc42.com, kriyatx.com, labiotech.eu, as cited on each company’s profile.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.